India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
What is DRS or Umpire Decision Review System in cricket? Cricket lovers must have heard about the Decision Review System or DRS and they must know how any team can challenge the decision of the umpire with the help of this rule of cricket. Recently some changes have also been made in this rule. With the help of these changes, this rule has been strengthened further. At the same time, a lot of criticism has also been made about this rule. After all, what is this rule and with the help of which technology this decision review system is used.